Content-Type: multipart/alternative;
 boundary="----=_NextPart_51043990.187877168357"
From: David Charest <dcharest@genomebc.ca>
To: Loren Rieseberg <loren.rieseberg@botany.ubc.ca>, John Burke
	<jmburke@uga.edu>, Emily Marden <emily.marden@gmail.com>, Brent Hulke
	<Brent.Hulke@ARS.USDA.GOV>, Lisa Donovan <ldonovan@uga.edu>
CC: Alison Dendoff <adendoff@genomebc.ca>, David Charest
	<dcharest@genomebc.ca>
Subject: Re: Key Genome BC Dates for Sunflower Project 
Thread-Topic: Key Genome BC Dates for Sunflower Project 
Thread-Index: AQHQSxeYg5i2LOHroUegwYcL7Duw9A==
Date: Wed, 18 Feb 2015 01:09:50 +0000
Message-ID: <D1092659.109E3%dcharest@genomebc.ca>
Accept-Language: en-US
Content-Language: en-US
MIME-Version: 1.0
Received-SPF: Pass (protection.outlook.com: domain of genomebc.ca designates
 66.119.182.58 as permitted sender) receiver=protection.outlook.com;
 client-ip=66.119.182.58; helo=SATURN.ms.genomebc.ca;
X-MS-Exchange-Transport-CrossTenantHeadersStamped: BN1AFFO11HUB033
X-MS-Exchange-Organization-MessageDirectionality: Incoming
Received-SPF: Pass (protection.outlook.com: domain of genomebc.ca designates
 65.55.169.55 as permitted sender) receiver=protection.outlook.com;
 client-ip=65.55.169.55; helo=na01-bl2-obe.outbound.protection.outlook.com;
Authentication-Results: spf=pass (sender IP is 65.55.169.55)
 smtp.mailfrom=dcharest@genomebc.ca; 
X-Forefront-Antispam-Report: CIP:65.55.169.55;CTRY:US;IPV:NLI;IPV:NLI;EFV:NLI;SFV:NSPM;SFS:(6009001)(438002)(584324002)(77156002)(15974865002)(2171001)(50986999)(47776003)(92566002)(19580405001)(36756003)(106466001)(450100001)(106116001)(50466002)(62966003)(19580395003)(83506001)(6806004)(104016003)(15975445007)(22756005)(2900100001)(102836002)(87836001)(23746002)(86362001)(46102003)(561944003)(54356999)(74482002)(2656002)(7059030);DIR:INB;SFP:;SCL:1;SRVR:CY1PR0201MB0842;H:na01-bl2-obe.outbound.protection.outlook.com;FPR:;SPF:Pass;MLV:sfv;LANG:en;
X-MS-Exchange-Transport-CrossTenantHeadersStripped: BY2FFO11FD016.protection.gbl
X-MS-Exchange-Transport-CrossTenantHeadersPromoted: BY2FFO11FD016.protection.gbl
X-MS-Exchange-Organization-Network-Message-Id: f9107b2d-f845-4563-07c2-08d2192ec01b
X-Microsoft-Antispam: BCL:0;PCL:0;RULEID:;SRVR:CY1PR0201MB0842;
X-MS-Exchange-Organization-AVStamp-Service: 1.0
X-Exchange-Antispam-Report-CFA-Test: BCL:0;PCL:0;RULEID:(601004);SRVR:CY1PR0201MB0842;
X-MS-Exchange-Organization-SCL: 1
X-Exchange-Antispam-Report-CFA-Test: BCL:0;PCL:0;RULEID:;SRVR:CY1PR0201MB0842;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 18 Feb 2015 01:09:54.8617
 (UTC)
X-MS-Exchange-CrossTenant-Id: a8216c1e-4d63-4352-8c3b-50fa1f1475b1
X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=7e7e9eba-7179-48ba-9760-0035e63cf1f3;Ip=[66.119.182.58]
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: CY1PR0201MB0842
X-MS-Exchange-Organization-AuthSource: BY2FFO11FD016.protection.gbl
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Exchange-Transport-EndToEndLatency: 00:00:06.1429915

------=_NextPart_51043990.187877168357
Content-Type: text/plain;
 charset="utf-8"
Content-Transfer-Encoding: quoted-printable

Dear Loren and John,

I hope work on the full application is progressing well.   Even though you =
are still a few weeks away from the March 9 deadline for the first complete=
 draft, it is important that you look ahead to, and plan for, some the crit=
ical dates following that deadline.  Please reserve the following days in y=
our calendar =E2=80=94and make sure key team members not included on this e=
mail do the same:

March 25-26  [Reviewer feedback]  Face-to-face meeting at Genome BC.   Foll=
owing submission of your draft to Genome BC on March 9th we will send it ou=
t to reviewers to get some feedback on your proposal which we will pass on =
to you on or about  ~March 20.  As the meeting on March 25-26  we will revi=
ew with you the feedback from the reviewers and work with you to address an=
y deficiencies in the proposal and enhance its strengths.  Participants in =
this meeting should include: Pis and key science leads, the GELS lead, indu=
stry/user representation and the project manager with which you are working.

May 14/15 [Mock panel review] Face-to-face meeting at Genome BC.  In this m=
eeting 4-5 key members of the team (2PI s, GELS lead and industry Rep/End U=
ser/key co-applicants/Project Manager depending on number of participants a=
llowed) will undergo a Panel simulation in preparation for the Genome Canad=
a Panel Review two weeks later.

May 27-29 [Genome Canada Panel Review] Face-to-face meeting outside BC (TBD=
) In this meeting 4-5 key members of the team (as above) and Genome BC pers=
onel will travel outside BC (TBD) for the formal Panel Review with Genome C=
anada.

The May 27/29 dates are fixed (we are not sure which day it will be yet, bu=
t it will be one of those three). If key personnel in your team have any ma=
jor conflicts please let us know immediately.

Alison Dendoff (adendoff@genomebc.ca) and team will be in contact nearer th=
ese dates with more information.

Best regards

David



David CHAREST Ph.D.
Director, Sector Development
Genome British Columbia
400 - 575 West 8th Avenue, Vancouver, BC V5Z 1C6
Tel: 604-637-4387 Mobile: 604-779-6261 Fax: 604-738-8597
dcharest@genomebc.ca<mailto:dcharest@genomebc.ca> - www.genomebc.ca<http://=
www.genomebc.ca/>

"A catalyst for a vibrant genomics-driven- life sciences cluster on Canada'=
s West Coast"

------=_NextPart_51043990.187877168357
Content-Type: text/rtf;
 charset="utf-8"
Content-Transfer-Encoding: quoted-printable

{\rtf1\ansi\ansicpg1252\fromtext \fbidis \deff0{\fonttbl=0A=0D{\f0\fswiss\f=
charset0 Arial;}=0A=0D{\f1\fmodern Courier New;}=0A=0D{\f2\fnil\fcharset2 S=
ymbol;}=0A=0D{\f3\fmodern\fcharset0 Courier New;}}=0A=0D{\colortbl\red0\gre=
en0\blue0;\red0\green0\blue255;}=0A=0D\uc1\pard\plain\deftab360 \f0\fs20 De=
ar Loren and John,\par=0A=0D\par=0A=0DI hope work on the full application i=
s progressing well.   Even though you are still a few weeks away from the M=
arch 9 deadline for the first complete draft, it is important that you look=
 ahead to, and plan for, some the critical dates following that deadline.  =
Please reserve the following days in your calendar \'97and make sure key te=
am members not included on this email do the same:\par=0A=0D\par=0A=0DMarch=
 25-26  [Reviewer feedback]  Face-to-face meeting at Genome BC.   Following=
 submission of your draft to Genome BC on March 9th we will send it out to =
reviewers to get some feedback on your proposal which we will pass on to yo=
u on or about  ~March 20.  As the meeting on March 25-26  we will review wi=
th you the feedback from the reviewers and work with you to address any def=
iciencies in the proposal and enhance its strengths.  Participants in this =
meeting should include: Pis and key science leads, the GELS lead, industry/=
user representation and the project manager with which you are working.\par=
=0A=0D\par=0A=0DMay 14/15 [Mock panel review] Face-to-face meeting at Genom=
e BC.  In this meeting 4-5 key members of the team (2PI s, GELS lead and in=
dustry Rep/End User/key co-applicants/Project Manager depending on number o=
f participants allowed) will undergo a Panel simulation in preparation for =
the Genome Canada Panel Review two weeks later.\par=0A=0D\par=0A=0DMay 27-2=
9 [Genome Canada Panel Review] Face-to-face meeting outside BC (TBD) In thi=
s meeting 4-5 key members of the team (as above) and Genome BC personel wil=
l travel outside BC (TBD) for the formal Panel Review with Genome Canada.\p=
ar=0A=0D\par=0A=0DThe May 27/29 dates are fixed (we are not sure which day =
it will be yet, but it will be one of those three). If key personnel in you=
r team have any major conflicts please let us know immediately.\par=0A=0D\p=
ar=0A=0DAlison Dendoff (adendoff@genomebc.ca) and team will be in contact n=
earer these dates with more information.\par=0A=0D\par=0A=0DBest regards\pa=
r=0A=0D\par=0A=0DDavid\par=0A=0D\par=0A=0D\par=0A=0D\par=0A=0DDavid CHAREST=
 Ph.D.\par=0A=0DDirector, Sector Development\par=0A=0DGenome British Columb=
ia\par=0A=0D400 - 575 West 8th Avenue, Vancouver, BC V5Z 1C6\par=0A=0DTel: =
604-637-4387 Mobile: 604-779-6261 Fax: 604-738-8597\par=0A=0Ddcharest@genom=
ebc.ca<mailto:dcharest@genomebc.ca> - www.genomebc.ca<http://www.genomebc.c=
a/>\par=0A=0D\par=0A=0D"A catalyst for a vibrant genomics-driven- life scie=
nces cluster on Canada's West Coast"\par=0A=0D}
------=_NextPart_51043990.187877168357--